|
Market Closed -
London S.E.
11:35:17 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 82.50 GBX | 0.00% |
|
+13.79% | +2.48% |
| 10-15 | Arecor Therapeutics Obtains Patents in Europe, US, India, for Rapid-acting Insulin | MT |
| 10-15 | Arecor Therapeutics Plc Strengthens Patent Protection For Its Proprietary AT278 Product | CI |
Evolution of the Average Target: Arecor Therapeutics plc
Evolution of the Target Price: Arecor Therapeutics plc
Changes in Analyst Recommendations: Arecor Therapeutics plc
5f9cf5af3faa47ad35697399e17787.nXhyNT59NCvXrjx-npws3sVspz2Lh_rdOTkYOxCarzA.2TcVRXtPDFnh9l1J_dp1gY0aymvqwo-rXHMtWFLgmWSlGUtFTwltQub3dQ~774a9424f0a13b3615cd00169759d7ab
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | +203.64% | ||||
| +24.19% | |||||
| +33.33% | |||||
| +14.65% | |||||
| +10.55% | |||||
| +36.95% | |||||
| +16.48% | |||||
| +47.08% | |||||
| +22.87% | |||||
| +29.34% | |||||
| Average | +43.91% | |||||
| Weighted average by Cap. | +25.20% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8250GBP
Average target price
2.505GBP
Spread / Average Target
+203.64%
High Price Target
2.510GBP
Spread / Highest target
+204.24%
Low Price Target
2.500GBP
Spread / Lowest Target
+203.03%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- AREC Stock
- Consensus Arecor Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
